JAN (NYSE:JAN) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

JAN (NYSE:JANGet Free Report) had its price objective lifted by equities researchers at Cantor Fitzgerald from $30.00 to $34.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 11.52% from the stock’s previous close.

JAN has been the topic of several other reports. Raymond James Financial assumed coverage on JAN in a research note on Tuesday, June 16th. They set a “strong-buy” rating and a $34.00 price objective on the stock. Barclays upped their target price on shares of JAN from $30.00 to $33.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Morgan Stanley assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They set an “overweight” rating and a $28.00 price target on the stock. BNP Paribas Exane initiated coverage on shares of JAN in a report on Tuesday, April 14th. They set an “outperform” rating and a $27.00 price target on the stock. Finally, KeyCorp upped their price objective on shares of JAN from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 10th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $29.85.

Get Our Latest Research Report on JAN

JAN Trading Up 1.9%

Shares of JAN stock opened at $30.49 on Thursday. The stock has a market capitalization of $8.02 billion, a P/E ratio of -609.74 and a beta of 2.16. JAN has a 52 week low of $22.76 and a 52 week high of $32.83. The business has a 50 day moving average of $28.25.

JAN (NYSE:JANGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.23 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.23. The company had revenue of $200.35 million for the quarter, compared to analysts’ expectations of $157.96 million.

Key Stories Impacting JAN

Here are the key news stories impacting JAN this week:

  • Positive Sentiment: Janus Living reported quarterly EPS of $0.24, ahead of the $0.23 consensus estimate. Revenue rose 45.4% year over year to $216.46 million, exceeding expectations of $203.32 million. Janus Living quarterly earnings report
  • Positive Sentiment: Management emphasized a debt-free balance sheet and growth initiatives, which may support investor confidence by reducing financial risk and providing flexibility to invest in expansion. Janus Living boosts outlook on debt-free growth
  • Positive Sentiment: The company’s latest revenue performance materially exceeded the prior consensus forecast, reinforcing the narrative of accelerating demand and operational momentum.
  • Neutral Sentiment: Janus Living issued fiscal 2026 EPS guidance of $0.95 to $0.98, compared with the $0.97 analyst consensus. The range is broadly in line with expectations, limiting the potential for a major forecast-driven repricing.
  • Neutral Sentiment: Investors are likely to focus on whether the company can sustain its rapid revenue growth while preserving margins and executing its expansion plans without taking on debt. Janus Living Q2 2026 earnings call transcript

About JAN

(Get Free Report)

Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.

Further Reading

Analyst Recommendations for JAN (NYSE:JAN)

Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.